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To help understand the potential impact of bacterial coinfection during pandemic inﬂuenza periods, we undertook a far-reaching
review of the existing literature to gain insights into the interaction of inﬂuenza and bacterial pathogens. Reports published
between 1950 and 2006 were identiﬁed from scientiﬁc citation databases using standardized search terms. Study outcomes related
to coinfection were subjected to a pooled analysis. Coinfection with inﬂuenza and bacterial pathogens occurred more frequently
in pandemic compared with seasonalinﬂuenza periods. The mostcommonbacterial coinfections withinﬂuenza virus were due to
S. pneumoniae, H. inﬂuenzae, Staphylococcus spp., and Streptococcus spp.O ft h e s e ,S. pneumoniae was the most common cause of
bacterial coinfection with inﬂuenza and accounted for 40.8% and 16.6% of bacterial coinfections during pandemic and seasonal
periods,respectively. Theseresultssuggestthatbacterial pathogenswillplayakeyroleinmanycountries,astheH1N1(A)inﬂuenza
pandemicmoves forward. Given the role ofbacterial coinfections during inﬂuenza epidemics andpandemics,the conduct ofwell-
designed ﬁeld evaluations of public health measures to reduce the burden of these common bacterial pathogens and inﬂuenza in
at-risk populations is warranted.
1.Introduction
Worldwide, seasonal inﬂuenza causes an estimated one mil-
lion deaths, and Streptococcus pneumoniae is associated with
approximately 875,000deathsamong children and ∼1.1 mil-
lion deaths among adults each year [1–3]. Inﬂuenza and S.
pneumoniae account for a large proportion of total respir-
atory disease morbidity and mortality. In addition, bacteri-
al coinfection due to pathogens such as S. pneumoniae is a
recognizedcomplicationofbothupperandlowerrespiratory
tract disease due to inﬂuenza [4, 5].
With the continued spread of H1N1 inﬂuenza virus
and the declaration of a global H1N1 inﬂuenza pandemic,
the impact of this virus may greatly increase in coming
months—particularly in populations where there is limited
access to health care. In recent years, as pandemic prepared-
nessactivitieshaveadvancedthroughouttheworld,thetreat-
ment, themanagement, theand preventionof bacterial coin-
fections (e.g., S. pneumoniae, Haemophilus inﬂuenzae type b
[Hib])havegarneredincreasingattention[6].Tohelpunder-
stand the potential impact of vaccination against coinfection
during pandemic inﬂuenza periods, we undertook a broad2 Interdisciplinary Perspectives on Infectious Diseases
review of the existing literature that provides new insights
into the interaction of inﬂuenza and bacterial pathogens.
2.Methods
2.1. Searching Strategy. In this study, we sought to examine
the available evidence from published studies to describe the
frequency of bacterial etiologies responsible for coinfection
with inﬂuenza virus. Studies of the association between
inﬂuenza and bacterial coinfections, including the impact of
S. pneumoniae vaccines, were identiﬁed using standardized
search algorithms for systematic reviews [7, 8]. Published
articlesintheEnglishandnon-English literatureweresought
through systematic searching of local and international
electronic databases. To facilitate identiﬁcation of published
literature,we accessed PubMed(UnitedStates),Chinese Bio-
Medicine (CBM, China), OVID (Ovid Technologies, Inc.,
United States), ISI Web of Knowledge (Thomson Reuters,
United States), and Korean Medline (KoreaMed, Korea).
The reviewincludedarticlespublished between 1918and
2006. Due to limitations in currently available electronic
databases, articles published before 1950 were identiﬁed
from publication reference lists obtained from scientiﬁc
periodicals, books, and other publications. Because of the
limited availability of electronic citations for studies related
to the ﬁrst inﬂuenza pandemic in the 20th century, we
performed a hand search covering all issues of JAMA and
the Lancet published in 1918 and 1919. Studies of pandemic
inﬂuenza were identiﬁed based on text or data reported in
publications that referred to patients who became ill during
any of the inﬂuenza pandemics of 1918, 1957, or 1968.
To conduct the literature search, medical subject head-
ing (MeSH) terms (inﬂuenza, human, pneumonia, bacte-
ria, pneumococcal infections, superinfection, pneumococcal
infections, complications, pandemic, and immunization)
and free words (coinfection, polymicrobial, predispose, and
bacterial coinfection) were used to identify reports. This list
of MeSH terms and free words was evaluated in a pilot study
to conﬁrm their ability to identify relevant scientiﬁc publi-
cations. Combinations of these MeSH terms and free words
were then constructed for literature searching. In addition,
the search terms and their combinations were translated into
standard Korean and Chinese medical terminology prior to
searching non-English electronic databases.
2.2.ReviewingStrategy. Usingthedatabasesidentiﬁedabove,
all studies published from 1950 to 2006 in English and non-
English languages were tabulated for initial review. Studies
were excluded from this paper if they met one of the follow-
ing criteria: (a) had no extractable data or studies limited
to single patients (e.g., case reports), (b) had no dates of
collection for data reported. Endnote (version X, Thomson,
Inc., Philadelphia, USA) bibliographic software was used
to create an electronic library of citations identiﬁed in our
database searches. PubMed searches were performed using
Endnote software, and references from each search were
imported to Endnote software databases. Study references
that could not be uploaded directly into Endnote software
(these included references identiﬁed in published paper
reference lists or identiﬁed through other hand searches)
were entered manually into study reference databases. After
deleting duplicate records, each study was assigned a unique
identiﬁcationcodetoenabletrackingofreviews and analysis.
Each citation was then screened by reviewing the text for
all report titles and abstracts. Studies that did not meet the
inclusion criteria in this study were excluded from the full-
text review. All remaining papers and reports underwent
full-text review by two independent study reviewers. From
each study, the following information was abstracted: design
of study, geographic location of study, study time period
(month, year), study duration (months or years), total
number of study patients, number of patients with bacterial
coinfections, types of bacterial pathogens responsible for
coinfection,aswellasmethodofinﬂuenzavirusandbacterial
coinfection diagnosis. Kappa (κ) statistics were calculated
for the interreviewer agreement during the title/abstract and
full-text evaluations using Stata 9.2 (StataCorp LP, College
Station, Tex). Reports that yielded conﬂicting information
among study reviewers were discussed with coinvestigators
to obtain consensus.
2.3. Deﬁnitions. To identify a case of suspected inﬂuenza
virus infection, the study had to report patients as having at
leastoneormore ofthefollowing clinicalsignsorsymptoms:
rapid onset of chills and high fever, frequent epistaxis,
myalgia and arthralgia, prostration, pharyngitis withoutton-
sillitis, rhinorrhea and cough with or without sputum, and
with or without evidence of chest radiograph abnormalities.
A diagnosis of conﬁrmed inﬂuenza virus infection was iden-
tiﬁed when, in addition to the symptoms mentioned above,
there was also evidence on laboratory testing of inﬂuenza
virus infection from (a) a rapid diagnostic test, (b) enzyme
immunoassay, (c) isolation of the virus in tissue-cell culture,
(d) direct or indirect immunoﬂuorescent antibody staining,
(e) reverse transcriptase-polymerase chain reaction (RT-
PCR) analysis, or (f) immunohistochemistry. Inﬂuenza
pneumonia was deﬁned by evidence of an acute pulmonary
inﬁltrate on the chest radiograph. A bacterial coinfection
was deﬁned by a positive laboratory test for any bacterial
pathogen in a patient with evidence of either clinical or
laboratory-conﬁrmed inﬂuenza.
2.4. Data Analysis. All studies included in this paper under-
went data extraction by trained study personnel and data
were entered into an MS Excel (Microsoft, Inc., Redmond,
Wash, USA) database. SAS statistical software was used for
analysis in this study (SAS Institute Inc., Cary, NC, USA).
To take into account variations in study designs, diagnostic
methods, study periods, and other study characteristics,
we utilized a random-eﬀe c t sm o d e lt oc a l c u l a t et h ep o i n t
estimates of log-transformed proportions (and rates) with
their associated 95% conﬁdence intervals [9–11]. The use
of the random-eﬀects model allowed for the inclusion of
covariates to reduce heterogeneity and for more speciﬁc
recommendations to be made from this analysis.Interdisciplinary Perspectives on Infectious Diseases 3
Studies were grouped into the following design cate-
gories: (a) descriptive studies (e.g., case series, cross-section-
al surveys, or surveillance studies), (b) analytic studies
(e.g., cohort or case-control studies), and (c) interventional
studies(e.g.,clinicaltherapeuticorvaccine trials). Toexplore
the potential association between inﬂuenza and bacteria
infections, studies were also stratiﬁed by type of bacterial
pathogen, pandemic period, and type of sample for bacteria
culture. The Kruskal-Wallis test was applied (using 0.05 as
the level of signiﬁcance) to compare the diﬀerence of propor-
tions of coinfection caused by S. pneumoniae, H. inﬂuenzae,
Streptococcus spp., and Staphylococcus spp. during seasonal
inﬂuenza and pandemic inﬂuenza periods.
This study was reviewed and approved by the Interna-
tional Vaccine Institute Institutional Review Board.
3.Results
The initial search identiﬁed 11,106 inﬂuenza and bacte-
ria infection-related citations. After exclusion of duplicate
records, a total of 9,587 and 674 studies were excluded using
review of title/abstract and full-text information, respec-
tively. Most of studies were excluded due to no extractable
data (Figure 1). The interobserver agreement was 86.3%
and 92.0% (P<. 05) for title/abstract and full-text screen,
respectively. Seventy-one published studies which met the
inclusion and exclusion criteria for this paper were included
in the ﬁnal analysis. Of these reports, 65 studies (91.5%)
were descriptive design. Most bacterial infections (93.0%)
were diagnosed with culture results, compared to 31.0%
cultural diagnosis of inﬂuenza (Table 1). Among the 71
articles included in the ﬁnal analysis, 56 reports presented
the data on the association between inﬂuenza and bacterial
coinfection. Of these, 39 (69.6%) reports originated from
either the USA or the UK with the remainder largely from
Japan and Spain (Appendix).
A pooled analysis showed that the most common bacte-
rial organisms causing coinfections were S. pneumoniae, H.
inﬂuenzae, Staphylococcus spp., and Streptococcus spp.F o ra l l
bacterial coinfections, rates of coinfection during pandemic
inﬂuenza transmission periods were higher than for seasonal
inﬂuenza (Table 2). S. pneumoniae was the most commonly
reported (40.8%) bacterial pathogen causing coinfections
with inﬂuenza during pandemic periods. H. inﬂuenzae
caused coinfection in 12.9% of patients with inﬂuenza,
while Staphylococcus spp. and Streptococcus spp.w a sf o u n d
in 25.0% and 15.7% of patients, respectively. In addition,
studies of seasonal inﬂuenza showed that S. pneumoniae was
the leading cause of bacterial coinfection (pooled average,
16.6%) followed by Staphylocccus spp. (6.2%), H. inﬂuenzae
(5.2%), and Streptococcus spp. (1.8%).
We conducted further analysis of bacterial coinfections
reported during three (1918, 1957, and 1968) inﬂuenza
pandemic periods (Table 3). Few studies were available from
the 1968 pandemic period, and data from these studies did
not contain suﬃcient patient numbers to permit calculation
of pooled proportions of coinfection. During the 1918
pandemic, S. pneumoniae caused the highest level (56.5%)
Exclusion of duplicate
reports
N = 755
Reports remaining after title screening
N = 764
Reports remaining after full-text screening
N = 71
Reports excluded following
full-text review
N = 674
Reports for which full
text was not available
N = 19
Published reports after searching
N = 11,106
Reports remaining after excluding duplicates
N = 10,351
R e p o r t se x c l u d e dw i t h
title screening
N = 9,587
Figure 1: Study ﬂow diagram showing review of reports.
Table 1: Characteristics of studies included in analysis (n = 71).
Characteristics Studies
(n) %
Study type
Descriptive 65 91.5
Analytic 2 2.8
Interventional 4 5.6
Study scope
Laboratory-based 1 1.4
Population-based 15 21.1
Hospital-based 55 77.5
Inﬂuenza diagnostic methods
Clinical diagnosis 32 45.1
Antigen/antibody detection 16 22.5
RT-PCR 1 1.4
Culture 22 31.0
Bacterial infection diagnostic methods
Clinical diagnosis 3 4.2
Antigen/antibody detection 2 2.8
Culture 66 93.0
Note: RT-PCR, reverse transcription-polymerase chain reaction.4 Interdisciplinary Perspectives on Infectious Diseases
Table 2: Pooled results of coinfecting bacterial pathogens identiﬁed with inﬂuenza virus during seasonaland pandemic inﬂuenza periods.
Bacteria Transmissionperiod Studies (n) Estimates from random eﬀects model
Average % coinfection with inﬂuenza virus 95% Conﬁdence interval
S. pneumoniae Seasonal 22 16.6a 7.9–31.6
Pandemic 35 40.8 30.5–52.0
H. inﬂuenzae Seasonal 10 5.2b 2.3–11.5
Pandemic 27 12.9 8.3–19.5
Streptococcus spp. Seasonal 7 1.8c 0.3–9.3
Pandemic 27 15.7 9.1–25.8
Staphylococcus spp. Seasonal 12 6.2d 2.3–15.7
Pandemic 26 25.0 15.4–37.8
aSeasonal versus pandemic pooled average proportion of patients with S. pneumoniae coinfection (P = .008, Kruskal-Wallis test; Bonferonni correction, α =
0.008).
bSeasonal versus pandemic pooled average proportion of patients with H. inﬂuenzae coinfection (P = .02, Kruskal-Wallis test; Bonferonni correction, α =
0.008).
cSeasonal versus pandemic pooled average proportion of patients with Streptococcus spp. coinfection (P = .009, Kruskal-Wallis test; Bonferonni correction,
α = 0.008).
dSeasonal versus pandemic pooled average proportion of patients with Staphylococcus spp. coinfection (P = .005, Kruskal-Wallis test; Bonferonni correction,
α = 0.008).
eDuring seasonal ﬂu period, the proportions of coinfection caused by S. pneumoniae, H. inﬂuenzae, Streptococcus spp., and Staphylococcus spp.w e r ed i ﬀerent.
(P = .009, Kruskal-Wallistest; Bonferonni correction, α = 0.008).
fDuring pandemic ﬂu period, the proportions of coinfection caused by S. pneumoniae, H. inﬂuenzae, Streptococcus spp., and Staphylococcus spp.w e r ed i ﬀerent.
(P<. 0001, Kruskal-Wallistest; Bonferonni correction, α = 0.008).
Table 3: Comparison of coinfection with major bacterial pathogens and inﬂuenza by pandemic period (n = 56)a,b.
Bacteria Pandemic period Studies (n) Estimates from random eﬀects model
Average % coinfection with inﬂuenza virus 95% Conﬁdence interval
S. pneumoniae
1918 23 56.5 45.6–66.8
1957 9 15.6 8.8–26.0
1968 3 27.8 2.9–83.2
H. inﬂuenzae
1918 17 17.9 9.9–30.3
1957 9 6.9 4.5–10.5
1968 1 6.3c —
Streptococcus spp.
1918 20 21.7 12.9–34.1
1957 6 4.6 0.6–28.2
1968 1 9.4c —
Staphylococcus spp.
1918 12 18.8 8.0–38.0
1957 11 39.7 20.9–62.2
1968 3 10.3 4.9–20.2
aProportions forS.pneumoniae,H.inﬂuenzae,Streptococcusspp.,andStaphylococcusspp.wer ediﬀerent(P<. 0001,Kruskal-Wallistest;Bonferonnicorrection,
α = 0.025) during 1918-1919 pandemic.
bProportionsforS.pneumoniae,H.inﬂuenzae,Streptococcusspp.,andStaphylococcusspp.wer ediﬀerent(P = .0006,Kruskal-Wallistest;Bonferonnicorrection,
α = 0.025) during 1957 pandemic.
cOriginal data.
of coinfection with inﬂuenza virus followed by Streptococcus
spp. (21.7%), Staphylococcus spp. (18.8%), and other H.
inﬂuenzae (17.9%). In studies around the 1957 pandemic
period, the most common cause ofbacterial coinfection with
inﬂuenza virus was Staphylococcus spp. (39.7%) followed by
S. pneumoniae (15.6%).
In the studies that contained suﬃcient data for full-text
review and data extraction during pandemic period, the
proportionsoforganisms causing coinfectionswere diﬀerent
while calculated by type of specimens utilized for bacterial
diagnosis (Table 4). Studies in which sputum or swab spec-
imens were used for bacterial isolation showed proportions
of coinfection ranging from 13.8% for Staphylococcus spp.,
14.6% for Streptococcus spp., 14.3% for H. inﬂuenzae, to
40.8% for S. pneumoniae (Kruskal-Wallis test, P = .0008).
However, among studies that utilized necropsy specimens to
detect coinfection, S. pneumoniae showed the highest rate
(46.5%) of coinfection closely followed by Staphylococcus
spp. (43.0%), Streptococcus spp. (19.6%), and H. inﬂuenzae
(17.6%) (Kruskal-Wallis test, P = .02).Interdisciplinary Perspectives on Infectious Diseases 5
Table 4: Comparison of coinfection with major bacterial pathogens and inﬂuenza by specimen type during pandemic inﬂuenza periodsa,b.
Bacteria Specimen Studies (n) Estimates from random eﬀects model
Average % coinfection with inﬂuenza virus 95% Conﬁdence interval
S. pneumonia
Sputum/swab 24 40.8 30.3–52.3
Sterile ﬂuid 4 7.0 2.1–21.4
Necropsy 12 46.5 24.8–69.7
H. inﬂuenza
Sputum/swab 17 14.3 8.6–23.1
Sterile ﬂuid 2 2.6 0.4–14.6
Necropsy 9 17.6 6.7–39.1
Streptococcus spp.
Sputum/swab 18 14.6 7.1–27.5
Sterile ﬂuid 2 1.4 0.02–46.4
Necropsy 12 19.6 9.5–36.2
Staphylococcus spp.
Sputum/swab 11 13.8 7.7–23.4
Sterile ﬂuid 2 2.7 0.5–14.1
Necropsy 11 43.0 20.8–68.5
aProportions for S. pneumoniae,H. inﬂuenzae, Streptococcus spp.a n dStaphylococcus spp.w e r ed i ﬀerent (P = .008, Kruskal-Wallistest: Bonferonni correction,
α = 0.025) while utilized sputum/swabspecimens to detect coinfection.
bProportions for S. pneumoniae, H. inﬂuenzae, Streptococcus spp.a n dStaphylococcus spp.w e r ed i ﬀerent (P = .02, Kruskal-Wallis test; Bonferonni correction,
α = 0.025) while utilized necropsy specimens to detect coinfection.
4.Discussion
The data synthesized in this paper indicate that S. pneu-
moniae is the leading cause of bacterial coinfection during
both seasonal and pandemic inﬂuenza periods, followed by
Staphylococcus spp., Streptococcus spp., and H. inﬂuenzae.
However, other major causes of invasive bacterial diseases
(e.g., Staphylococcus spp.) are close behind S. pneumoniae
as a cause of coinfection with inﬂuenza virus. These
data suggest that S. pneumoniae and Staphylococcus spp.
are leading causes of bacterial coinfection with inﬂuenza.
Interestingly, bacterial coinfection, as well as the relative
frequency concluded above, was also demonstrated by
several recent studies examining bacterial coinfection during
2009-2010 H1N1 pandemic [12–14]. Notably, the hierarchy
of bacterial coinfections identiﬁed in this review of studies
performed during inﬂuenza pandemic periods showed the
same order of importance as studies from interpandemic
periods. An important observation from our analysis was
thatthe proportion of patients with bacterial coinfectionwas
signiﬁcantly higher in the pandemic studies compared with
studies conducted during interpandemic periods.
Our review has some limitations. First, because of the
time period covered by this paper and advancement in lab-
oratory methods over the same period, the laboratory iden-
tiﬁcation of inﬂuenza virus and bacterial pathogens varied
during the study period. Thus, it is possible that more recent
studies had higher sensitivity or speciﬁcity for the detection
of both viruses and bacteria. In addition, it is possible
that other bacterial pathogens may be important but were
undetectedduetolimitationsinthelaboratorymethodsused
during diﬀerent time periods or in diﬀerent countries. In
this paper, we found a limited number of cohort studies
during either seasonal or pandemic inﬂuenza periods. As a
result, our analysis could not describe data in a well-deﬁned
cohort of inﬂuenza patientswho were followed prospectively
to assess rates of bacterial coinfection. Notwithstanding,
the bacterial coinfection and pattern concluded from our
analysis were illustrated again during the recent H1N1 pan-
demic [12–14]. Second, the ﬁndings suggest that bacterial
coinfection is higher in pandemic periods compared to
endemic periods. This observation might be attributable
to additional epidemiologic and clinical eﬀorts that are
carried out during studies falling within pandemic periods
compared with seasonal inﬂuenza periods. In fact, out of the
56 studies that provided coinfection data, 34 (60.7%) were
conducted during the pandemic period. An additional 22
(39.3%)studiesdescribedthepatternofbacterialcoinfection
during seasonal inﬂuenza periods. Moreover, most studies
identiﬁed in this paper, regardless of whether they were
conducted during pandemic or seasonal inﬂuenza periods,
applied hospital-based designs and focused on severely ill
patients with outcomes resulting in hospitalization or death.
Finally,theincreasing antimicrobialresistance[15,16]m ight
aﬀect the isolation of bacteria. In this analysis, all pandemic-
related studies in this paper were carried out before 1970.
Conversely, out of the 22 seasonal inﬂuenza studies, 19
(86.4%) were conducted after 1970. Thus, an underestima-
tion of bacterial coinfection in seasonal inﬂuenza studies
mayhaveoccurredwhere populationusageofantibioticswas
more prevalent.
Our analysis suggests that public health measures to
reduce the burden of bacterial coinfections is warranted.
In a study of pneumococcal vaccine eﬀectiveness in South
Africa, it appears that immunization with pneumococcal
conjugate vaccine (PCV) in children is associated with
moderate protection against inﬂuenza [17]. One potential
explanation of this eﬀe c ti st h a tP C Vr e d u c e sm u c o s a lc o l o -
nization by pneumococcal vaccine serotypes and engenders
herd protection against pneumococcal vaccine serotypes
among unvaccinated individuals. Inso doing,PCVindirectly
reduces severe pneumococcal infections that may be more6 Interdisciplinary Perspectives on Infectious Diseases
susceptible to inﬂuenza virus infection. A complementary
explanation mayrest in thefact thatPCVdirectlyreducesthe
burden of severe pneumococcal infections that also reduces
the number of individuals in the vaccinated population who
aresusceptibletoinﬂuenzavirusinfection.Alimitednumber
of studies have suggested that an excess burden of invasive
pneumococcal disease is associated with seasonal inﬂuenza
epidemics. In Sweden [18], a negative binomial model was
usedtoestimatetheexcessburdenofIPDusinginﬂuenzaand
IPD data between 1994 and 2004 from Swedish surveillance
system. This analysis showed a yearly increase of 72 to 118
cases of IPD attributable to inﬂuenza, which corresponded
to 6% to 10% overall per year or 12% to 20% during any
given inﬂuenza season. Based on our analysis of coinfection
studies, S. pneumoniae and other bacterial pathogens are
likely to reappear as a major cause of bacterial coinfection
in future inﬂuenza pandemics. Therefore, a key question
f o rp o l i c y m a k e r si sw h e t h e ro rn o tv a c c i n e sf o rp r e v e n t i o n
of invasive bacterial infections caused by S. pneumoniae
and other pathogens should play a more active role in
helping to prepare countries for pandemic inﬂuenza. Given
the likelihood of continuing inﬂuenza virus transmission in
present pandemic and bacterial coinfections that occur with
inﬂuenza, there is an urgent need to reevaluate the full range
of tools that may mitigate the burden of invasive bacterial
infection, including pneumococcal and Hib vaccines as
well as pharmacologic and nonpharmacologic interventions.
The evaluation of pneumococcal vaccines with or without
inﬂuenza vaccine to reduce the burden of coinfections
will require large-scale, carefully designed and appropriately
powered ﬁeld trials in orderto provide high-quality evidence
currently required by public health policymakers.
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